Alexandra Collingbourne Alexandra Collingbourne

Qureight appoints Rebecca Simmons as Chief Operating Officer

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Rebecca Simmons as Chief Operating Officer.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Qureight appoints Dr Steven Bishop as Chief Medical Officer

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Dr Steven Bishop as Chief Medical Officer (CMO). Previously Chief Data Officer, Steven’s new role reflects changes in company structure, in response to continued growth and commercial success.

Read More
Alexandra Collingbourne Alexandra Collingbourne

New trial for Walsall heart failure patients

Heart failure patients are being sought by Walsall researchers to take part in a trial to test a new device aimed at preventing deterioration and helping them avoid hospital admission.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Paragraf pioneers world-leading 6-inch wafer at its Cambridgeshire factory

Cambridge Cluster company Paragraf, which is pioneering the commercialisation of graphene-based electronics using standard semiconductor processes, has produced the first 6-inch wafer at its new manufacturing facility in Huntingdon – marking a significant expansion in the company’s production capability and technology platform.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Digital platform to tackle ADHD waiting list timebomb

Amid experts warning that ADHD patients are being left suicidal because of lack of medical support, a ground-breaking platform by Psyomics that can speed up access to services for diagnosis and treatment is being launched in the NHS.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery

Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory disease. Data demonstrate sensitive quantification of vascular remodelling and prediction of disease severity from routine CT scans, following surgical removal of chronic blood clots. Automated insights from application of Vascul8 model enabled identification of patients at high risk of residual pulmonary hypertension post-surgery which will reduce the need for routine post-operative right heart catheterisation.

Read More
Alexandra Collingbourne Alexandra Collingbourne

INTRATOMICS and UK’s Paragraf Sign MoU to Pioneer Next-Generation Graphene-Based Sensor Technologies

Khalifa University of Science and Technology today announced that INTRATOMICS Advanced Material Technologies (INTRATOMICS), a subsidiary of Khalifa University Enterprises Company (KUEC), has signed a memorandum of understanding (MoU) with Paragraf, the UK-based company pioneering the commercialization of graphene-based electronics using standard semiconductor processes, to jointly develop advanced graphene-enabled sensor solutions.


Read More